Similar articles

• Electrophysiological mechanisms in a canine model of erythromycin-associated long QT syndrome.

  Rubart M, Pressler ML, Pride HP, Zipes DP. Rubart M, et al. Circulation. 1993 Oct;88(4 Pt 1):1832-44. doi: 10.1161/01.cir.88.4.1832. Circulation. 1993. PMID: 8403329
• QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine.

  Lin JC, Quasny HA. Lin JC, et al. Pharmacotherapy. 1997 May-Jun;17(3):626-30. Pharmacotherapy. 1997. PMID: 9165570
• Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care.

  Roden DM, Woosley RL, Primm RK. Roden DM, et al. Am Heart J. 1986 Jun;111(6):1088-93. doi: 10.1016/0002-8703(86)90010-4. Am Heart J. 1986. PMID: 3716982
• The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis.

  Jackman WM, Friday KJ, Anderson JL, Aliot EM, Clark M, Lazzara R. Jackman WM, et al. Prog Cardiovasc Dis. 1988 Sep-Oct;31(2):115-72. doi: 10.1016/0033-0620(88)90014-x. Prog Cardiovasc Dis. 1988. PMID: 3047813 Review. No abstract available.
• The molecular basis of cardiac arrhythmias.

  Shivkumar K, Murali NS, Krishnan SC. Shivkumar K, et al. J Nucl Cardiol. 2002 Mar-Apr;9(2):206-14. doi: 10.1067/mnc.2002.122763. J Nucl Cardiol. 2002. PMID: 11986566 Review. No abstract available.